Skip to main content

Active Clinical Trials

For general information regarding clinical trials please contact: 

Debbie Hannah -- 919-681-5797 

Contact Dr. Hall’s office at 919-681-8368 for more information on these studies:

1. Pemphigus Vulgaris or Pemphigus Foliaceus: A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects with Chronic Pemphigus (Vulgaris or Foliaceus)

2. Active Pemphigus: A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults with Active Pemphigus.

Contact Dr. Cardones' Office at 919-684-1830 for more information on this trial:

1. Morphea: Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

 

Contact Dr. Olsen's Office at 919-668-5610 for more information on the following studies:

1. Alopecia Areata: A Randomized, Double-blind, Vehicle-controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-50002 Topical Solution Administered Twice-Daily for 6 Months in Adult Subjects with Stable Patchy Alopecia Areata

2. Mycosis Fungoides/CTCL: A randomized, double-blind, multi-centre, placebo-controlled, parallel-arm phase 2 trial to assess safety, efficacy and pharmacokinetics of CD11301 0.03% and 0.06% gel in the treatment of Cutaneous T-Cell Lymphoma(CTCL), stages IA, IB and IIA

3. Mycosis Fungoides or Sézary Syndrome/CTCL: A Double Blind, Randomized, Vehicle Controlled, Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion, 0.5%, for the Relief of Pruritus in Patients with the Mycosis Fungoides (MF) or Sézary Syndrome (SS) Forms of Cutaneous T-Cell Lymphoma (CTCL)